Clark Street Value

Showing posts with label OncoMed. Show all posts
Showing posts with label OncoMed. Show all posts
Friday, October 7, 2022

Mereo BioPharma: Activist Proxy Fight

›
Back in the March 2019, I wrote up the merger between U.K. based Mereo BioPharma (MREO) (~$100MM current market cap) and OncoMed Pharmaceut...
13 comments:
Friday, March 29, 2019

OncoMed Pharmaceuticals: Merger Arb + CVRs

›
OncoMed Pharmaceuticals (OMED) is the latest entry in my occasional series on busted biotechs, as the name suggests OncoMed is a development...
8 comments:
›
Home
View web version

About Me

MDC
Contact me at clarkstreetvalue@gmail.com
View my complete profile
Powered by Blogger.